Adagene Inc. Files 6-K Report
Ticker: ADAG · Form: 6-K · Filed: 2026-04-02T07:11:55-04:00
Sentiment: neutral
Topics: 6-K, foreign-issuer, disclosure
TL;DR
Adagene Inc. filed a 6-K on 4/2/26, standard foreign issuer report.
AI Summary
Adagene Inc. filed a Form 6-K on April 2, 2026, reporting information as a foreign issuer. The filing includes various exhibits such as the 6-K form itself, and exhibits related to legal matters and company information. The company's business address is located in Suzhou Industrial Park, Jiangsu, China.
Why It Matters
This filing provides routine updates for Adagene Inc. as a foreign issuer, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Adagene Inc. (company) — Filer of the report
- 0001818838 (company) — CIK number for Adagene Inc.
- 2026-04-02 (date) — Filing date of the 6-K report
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by SEC rules 13a-16 and 15d-16, used to submit information that the issuer makes public in its home country or that is required to be filed with a stock exchange on which it is listed.
When was this Form 6-K filed by Adagene Inc.?
This Form 6-K was filed on April 2, 2026.
What is Adagene Inc.'s CIK number?
Adagene Inc.'s CIK number is 0001818838.
Where is Adagene Inc.'s business address listed?
Adagene Inc.'s business address is listed as 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000.
What type of business is Adagene Inc. primarily involved in, according to the SIC code?
According to the SIC code (2834), Adagene Inc. is primarily involved in Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001104659-26-038868 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001104659-26-038868 Filing Date 2026-04-02 Accepted 2026-04-02 07:11:55 Documents 7 Period of Report 2026-04-02 Document Format Files Seq Description Document Type Size 1 FORM 6-K tm2610619d2_6k.htm 6-K 20169 2 EXHIBIT 1.1 tm2610619d2_ex1-1.htm EX-1.1 284285 3 EXHIBIT 5.1 tm2610619d2_ex5-1.htm EX-5.1 52672 4 EXHIBIT 8.1 tm2610619d2_ex8-1.htm EX-8.1 16927 5 EXHIBIT 99.1 tm2610619d2_ex99-1.htm EX-99.1 8648 6 GRAPHIC tm2610619d2_ex8-1img001.jpg GRAPHIC 16067 7 GRAPHIC tm2610619d2_ex5-1img001.jpg GRAPHIC 8596 Complete submission text file 0001104659-26-038868.txt 418130 Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632 Adagene Inc. (Filer) CIK : 0001818838 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 26830607 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)